Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Clinical trial NCT06687681 · RECRUITING

Trial details

NCT number: NCT06687681
Sponsor: Marzieh Ebrahimi
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioma Glioblastoma Multiforme High Grade Glioma (III or IV)

Start date: 2024-11-25
Primary completion: 2025-11-25
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.